These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4067639)
1. Radioimmunodetection in patients with suspected ovarian cancer. Pateisky N; Philipp K; Skodler WD; Czerwenka K; Hamilton G; Burchell J J Nucl Med; 1985 Dec; 26(12):1369-76. PubMed ID: 4067639 [TBL] [Abstract][Full Text] [Related]
2. Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer. Pateisky N; Philipp K; Sevelda P; Skodler WD; Enzelsberger H; Hamilton G; Burchell J; Schatten C Gynecol Obstet Invest; 1987; 24(3):211-6. PubMed ID: 3692333 [TBL] [Abstract][Full Text] [Related]
3. Clinical immunoscintigraphy of ovarian carcinoma using iodine-131-labeled 145-9 monoclonal antibody. Chung JK; Kang SB; Lee HP; Lee MC; Koh CS; Sakahara H; Endo K J Nucl Med; 1993 Oct; 34(10):1651-5. PubMed ID: 8410277 [TBL] [Abstract][Full Text] [Related]
4. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma]. Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855 [TBL] [Abstract][Full Text] [Related]
5. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report. Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532 [TBL] [Abstract][Full Text] [Related]
6. Strategies for the development of monoclonal antibodies for in vivo imaging: their use in the imaging of ovarian carcinoma. Burchell J; Taylor-Papadimitriou J; Griffiths AB Cancer Detect Prev Suppl; 1987; 1():241-7. PubMed ID: 3480054 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies for successful tumour imaging. Burchell J; Taylor-Papadimitriou J; Granowska M; Britton K Behring Inst Mitt; 1984 May; (74):87-93. PubMed ID: 6541035 [TBL] [Abstract][Full Text] [Related]
9. [Immunoscintigraphy of oncologic tumors]. Barzen G Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627 [TBL] [Abstract][Full Text] [Related]
10. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125. Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center]. Vuillez JP; Levrot E; Mousseau M; Buffaz PD; Bolla M; Payan R; Comet M; Schaerer R Bull Cancer; 1997 Nov; 84(11):1033-42. PubMed ID: 9536985 [TBL] [Abstract][Full Text] [Related]
13. Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours. Granowska M; Mather SJ; Jobling T; Naeem M; Burchell J; Taylor-Papadimitriou J; Shepherd J; Britton KE Int J Biol Markers; 1990; 5(2):89-96. PubMed ID: 2283483 [TBL] [Abstract][Full Text] [Related]
14. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies]. Peking A; Marinov V Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792 [TBL] [Abstract][Full Text] [Related]
15. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies]. Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446 [TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of three monoclonal antibodies to human ovarian epithelial adenocarcinomas. Qian HN; Feng J; Cui H; Fu TY; Wei P; Fu ZY Chin Med J (Engl); 1989 Nov; 102(11):839-43. PubMed ID: 2517724 [TBL] [Abstract][Full Text] [Related]
17. A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer. Granowska M; Britton KE; Shepherd JH; Nimmon CC; Mather S; Ward B; Osborne RJ; Slevin ML J Clin Oncol; 1986 May; 4(5):730-6. PubMed ID: 3701391 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay. Peltier P; Dutin JP; Chatal JF; Fumoleau P; Bourguet P; Liehn JC; Vuillez JP; Hérry JY; Loboguerrero A Ann Oncol; 1993 Apr; 4(4):307-11. PubMed ID: 8518221 [TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Low RN; Carter WD; Saleh F; Sigeti JS Radiology; 1995 May; 195(2):391-400. PubMed ID: 7724757 [TBL] [Abstract][Full Text] [Related]